Publications by authors named "S F Basir"

Background: Multiple sclerosis (MS) is a complex neurological disorder marked by neuroinflammation and demyelination. Understanding its molecular basis is vital for developing effective treatments. This study aims to elucidate the molecular progression of MS using multiomics and network-based approach.

View Article and Find Full Text PDF

Aberrant accumulation of protein misfolding can cause aggregation and fibrillation and is one of the primary characteristic features of neurodegenerative diseases. Because they are disordered, misfolded, and aggregated proteins pose a significant setback in drug designing. The structural study of intermediate steps in these kinds of aggregated proteins will allow us to determine the conformational changes as well as the probable pathways encompassing various neurodegenerative disorders.

View Article and Find Full Text PDF

Pleural hemangiopericytoma/solitary fibrous tumor (HPC/SFT) is a rare form of mesenchymal tumor arising from pericytes, which predominantly occurs intrathoracically. HPC/SFT can be suspected on imaging, but radiographic features are non-specific. Therefore, histological confirmation remains the gold standard.

View Article and Find Full Text PDF

Amyloidosis of protein caused by fibrillation and aggregation are some of the most exciting new edges not only in protein sciences but also in molecular medicines. The present review discusses recent advancements in the field of neurodegenerative diseases and therapeutic applications with ongoing clinical trials, featuring new areas of protein misfolding resulting in aggregation. The endogenous accretion of protein fibrils having fibrillar morphology symbolizes the beginning of neuro-disorders.

View Article and Find Full Text PDF
Article Synopsis
  • Camelid-derived single-domain antibodies (VHs) are effective in studying diverse surface proteins' antigenic properties, specifically in Lyme disease research.
  • Two alpacas were immunized to create a phage-displayed VH library against an important Lyme vaccine antigen, outer surface protein A (OspA), leading to the identification of 21 unique VHs.
  • The study highlights that these VHs exhibit different reactivities across various OspA serotypes, indicating the need for considering unique epitopes when developing multivalent Lyme disease vaccines.
View Article and Find Full Text PDF